JG
INBX icon

Jain Global’s Inhibrx INBX Stock Holding History

Jain Global’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
+3,298
New +$330K ﹤0.01% 1373
2026
Q1 		– Sell
-12,098
Closed -$956K – 1418
2025
Q4 		$956K Buy
+12,098
New +$824K ﹤0.01% 713

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jain Global's INBX Position: Q2 2026 in Review

Jain Global opened a new position in Inhibrx (INBX) in Q2 2026: 3,298 shares worth $312K. The stake represents ﹤0.01% of the portfolio and ranks #1373 among its holdings. This is a return to the name: Jain Global previously reported a position in INBX as recently as Q4 2025.

Jain Global first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. The position peaked at $956K in Q4 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Jain Global held 3,298 shares of Inhibrx worth $312K as of Q2 2026.
  • Inhibrx was a new Jain Global position in Q2 2026.
  • Inhibrx made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1373 holding.
  • Jain Global first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • Jain Global's Inhibrx position peaked at $956K in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.